Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
- Status
- TERMINATED
- Phase
- NA
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- Status
- RECRUITING
- Phase
- PHASE2
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplantation for Sickle Cell Anemia
- Status
- COMPLETED
- Phase
- PHASE3
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
- Status
- COMPLETED
- Phase
- PHASE1
Non-Myeloablative Conditioning and Bone Marrow Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
T&B Depletion Non Malignant
- Status
- UNKNOWN
- Phase
- PHASE2
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2